DexCom Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/27/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
DexCom (DXCM) PT Raised to $170 at Stephens
November 7, 2018 8:34 AM ESTStephens analyst Chris Cooley raised the price target on DexCom (NASDAQ: DXCM) to $170.00 (from $160.00) while maintaining a Overweight rating following the company's 3Q report. Sales were in-line with Stephens' well-above consensus revenue estimate.
DXCM appears well positioned to continue to deliver... More
DexCom (DXCM) Tops Q3 EPS by 27c, Revenues Beat; Lifts FY18 Revenue Outlook Above Consensus
November 6, 2018 4:02 PM ESTDexCom (NASDAQ: DXCM) reported Q3 EPS of $0.17, $0.27 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $266.7 million versus the consensus estimate of $241.3 million.
Dexcom has maintained the strong momentum we have seen all year, with sales up 45% on a constant... More
